Though an estimated 60 million people around the world have atrial fibrillation, or A-fib, a type of irregular and often fast ...

Valvular heart disease, identified through cardiovascular imaging, is common in cancer patients. Interventions to treat ...

Valvular heart disease, identified through cardiovascular imaging, is common in cancer patients. Interventions to treat ...

Heart issues often show up without anyone noticing. They mix in with normal aging or changes in routine. Small shifts in breathing, energy, or appearance can sometimes carry more meaning than they ...

PHOENIX — Imagine having a heart condition so severe you can’t walk to your mailbox — and then being told you’re too sick for treatment. That’s been the reality for thousands of people suffering from ...

A new at-home injection has been approved for use on the NHS, offering a significant breakthrough for approximately 1,500 individuals in England and Wales living with a rare heart condition. The ...

New research suggests root canal treatment, beyond saving teeth, may significantly lower risks of heart disease and type 2 diabetes. By eliminating hidden dental infections, this procedure appears to ...

New study has discovered a groundbreaking technology that is showing remarkable success in significantly reducing bad cholesterol and triglycerides in a single treatment. This scientific advancement ...

With new phase 3 data backing the ability of its emergency use zalunfiban to fend off further heart damage, CeleCor Therapeutics is one step closer to bringing a speedy new weapon to the race against ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Panelists discuss how mineralocorticoid receptor antagonists (MRAs) remain underutilized despite being foundational therapy for heart failure with reduced ejection fraction due to clinician fears of ...

A promising “two-in-one” experimental drug could tackle both type 2 diabetes and heart disease by slashing cholesterol and inflammation, potentially offering a powerful new way to protect the heart ...